Tezepelumab PRO Study
Clinical trial NCT05922891 · COMPLETED
Trial details
- NCT number
- NCT05922891
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-27
- Primary completion
- 2025-09-20
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.